Sugammadex in Emergency Situations
- PMID: 36675820
- PMCID: PMC9867288
- DOI: 10.3390/jpm13010159
Sugammadex in Emergency Situations
Abstract
Sugammadex may be required or used in multiple emergency situations. Moderate and high doses of this compound can be used inside and outside the operating room setting. In this communication, recent developments in the use of sugammadex for the immediate reversal of rocuronium-induced neuromuscular blockade were assessed. In emergency surgery and other clinical situations necessitating rapid sequence intubation, the tendency to use rocuronium followed by sugammadex instead of succinylcholine has been increasing. In other emergency situations such as anaphylactic shock caused by rocuronium or if intubation or ventilation is not possible, priority should be given to resuming ventilation maintaining hemodynamic stability, in accordance with the traditional guidelines. If necessary for the purpose of resuming ventilation, reversal of neuromuscular blockade should be done in a timely fashion.
Keywords: emergency situation; neuromuscular blockade; reversal; rocuronium; sugammadex.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
[Rocuronium and sugammadex in emergency medicine: requirements of a muscle relaxant for rapid sequence induction].Anaesthesist. 2014 Apr;63(4):331-7. doi: 10.1007/s00101-014-2303-1. Anaesthesist. 2014. PMID: 24595442 Review. German.
-
The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.Anesth Analg. 2016 Jul;123(1):82-92. doi: 10.1213/ANE.0000000000001347. Anesth Analg. 2016. PMID: 27140684
-
Utility of neuromuscular blockade reversal in the evaluation of acute neurosurgical patients: A retrospective case-series.J Clin Neurosci. 2022 Oct;104:82-87. doi: 10.1016/j.jocn.2022.08.009. Epub 2022 Aug 16. J Clin Neurosci. 2022. PMID: 35981464
-
Safety and Efficacy of Rocuronium With Sugammadex Reversal Versus Succinylcholine in Outpatient Surgery-A Multicenter, Randomized, Safety Assessor-Blinded Trial.Am J Ther. 2016 Nov/Dec;23(6):e1654-e1662. doi: 10.1097/MJT.0000000000000206. Am J Ther. 2016. PMID: 25768376 Clinical Trial.
-
What is the Role of Sugammadex in the Emergency Department?J Emerg Med. 2021 Jan;60(1):44-53. doi: 10.1016/j.jemermed.2020.08.006. Epub 2020 Sep 19. J Emerg Med. 2021. PMID: 32962903 Review.
Cited by
-
Reducing Sugammadex Expenditure through Educational Initiatives in an Urban Tertiary Care Hospital System: A Cost-Reduction Study.Can J Hosp Pharm. 2025 Feb 12;78(1):e3648. doi: 10.4212/cjhp.3648. eCollection 2025. Can J Hosp Pharm. 2025. PMID: 39944759 Free PMC article.
-
Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.J Clin Med. 2024 Feb 19;13(4):1182. doi: 10.3390/jcm13041182. J Clin Med. 2024. PMID: 38398494 Free PMC article. Review.
References
-
- Welliver M. New drug sugammadex: A selective relaxant binding agent. AANA J. 2006;74:357–363. - PubMed
-
- Hristovska A.M., Duch P., Allingstrup M., Afshari A. The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta—Analysis and trial sequential analysis. Anaesthesia. 2018;73:631–641. doi: 10.1111/anae.14160. - DOI - PubMed
LinkOut - more resources
Full Text Sources